CEO to attend the Dermatology Drug Development Summit in Boston

Blueberry CEO, John Ridden, will be attending the 2nd Dermatology Drug Development Summit in Boston, 27-29th November 2018. The event is a unique industry-led conference focusing on innovating & accelerating the development amd commercialisation of dermatological medicines.

2018-12-07T10:20:01+00:00 November 23rd, 2018|